STOCK TITAN

Marvell COO Chris Koopmans' trust sells 10,000 shares

The sales were made under a Rule 10b5-1 plan Chris Koopmans adopted on June 16, 2026, with transaction prices ranging from $183.20 to $191.86.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Marvell Technology, Inc. President and COO Chris Koopmans reported the sale of 10,000 common shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust on November 2, 2026, at a weighted average price of $186.97 per share. The sales were made under a Rule 10b5-1 plan Chris Koopmans adopted on June 16, 2026; prices ranged from $183.20 to $191.86. The reported position following the sale was 202,800 shares held indirectly through the trust.

Insider Koopmans Chris
Role President and COO
Sold 10,000 shs ($1.87M)
Type Security Shares Price Value
Sale Common Stock F1, F2, F3 10,000 $186.97 $1.87M
Holdings After Transaction: Common Stock — 202,800 shares (Indirect, By Trust)
Footnotes (3)
  1. F1. Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on June 16, 2026.
  2. F2. The price reported is a weighted average price rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $183.20 to $191.86, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  3. F3. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.
Shares sold 10,000 shares November 2, 2026, sale held by the family trust
Weighted average sale price $186.97 per share Rounded to the nearest cent
Sale price range $183.20 to $191.86 per share Prices across multiple transactions, inclusive
Shares following transaction 202,800 shares Reported as held indirectly through the trust following the sale
10b5-1 Plan regulatory
"Sales were made pursuant to a 10b5-1 Plan"
A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.
weighted average price financial
"The price reported is a weighted average price rounded to the nearest cent"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Family Trust technical
"Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MRVL shares did the Koopmans family trust sell, and at what price?

The Christopher R. Koopmans and Heather J. Koopmans Family Trust sold 10,000 Marvell common shares on November 2, 2026, at a weighted average price of $186.97 per share. The sales were made in multiple transactions priced from $183.20 to $191.86 under a Rule 10b5-1 plan Chris Koopmans adopted on June 16, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Koopmans Chris

(Last)(First)(Middle)
5488 MARVELL LANE

(Street)
SANTA CLARA CALIFORNIA 95054

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Marvell Technology, Inc. [ MRVL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President and COO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/02/2026S(1)10,000D$186.97(2)202,800IBy Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on June 16, 2026.
2. The price reported is a weighted average price rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $183.20 to $191.86, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
3. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.
Remarks:
Christopher Koopmans by Blair Walters as Attorney-in-Fact11/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading